DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Conroy T, Hammel P, Hebbar M. et al.
FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer.
N Engl J Med 2018;
379: 2395-2406 doi:10.1056/NEJMoa1809775
We do not assume any responsibility for the contents of the web pages of other providers.